scholarly journals Extracellular Fibrillar Structure of Latent TGFβ Binding Protein-1: Role in TGFβ-dependent Endothelial-Mesenchymal Transformation during Endocardial Cushion Tissue Formation in Mouse Embryonic Heart

1997 ◽  
Vol 136 (1) ◽  
pp. 193-204 ◽  
Author(s):  
Yuji Nakajima ◽  
Kohei Miyazono ◽  
Mitsuyasu Kato ◽  
Masao Takase ◽  
Toshiyuki Yamagishi ◽  
...  

Transforming growth factor-β (TGFβ) is a dimeric peptide growth factor which regulates cellular differentiation and proliferation during development. Most cells secrete TGFβ as a large latent TGFβ complex containing mature TGFβ, latency associated peptide, and latent TGFβ-binding protein (LTBP)-1. The biological role of LTBP-1 in development remains unclear. Using a polyclonal antiserum specific for LTBP-1 (Ab39) and three-dimensional collagen gel culture assay of embryonic heart, we examined the tissue distribution of LTBP-1 and its functional role during the formation of endocardial cushion tissue in the mouse embryonic heart. Mature TGFβ protein was required at the onset of the endothelial-mesenchymal transformation to initiate endocardial cushion tissue formation. Double antibody staining showed that LTBP-1 colocalized with TGFβ1 as an extracellular fibrillar structure surrounding the endocardial cushion mesenchymal cells. Immunogold electronmicroscopy showed that LTBP-1 localized to 40–100 nm extracellular fibrillar structure and 5–10-nm microfibrils. The anti–LTBP-1 antiserum (Ab39) inhibited the endothelial-mesenchymal transformation in atrio-ventricular endocardial cells cocultured with associated myocardium on a three-dimensional collagen gel lattice. This inhibitory effect was reversed by administration of mature TGFβ proteins in culture. These results suggest that LTBP-1 exists as an extracellular fibrillar structure and plays a role in the storage of TGFβ as a large latent TGFβ complex.

2008 ◽  
Vol 45 (6) ◽  
pp. 571-582 ◽  
Author(s):  
Brenda C. Frazier ◽  
Mark P. Mooney ◽  
H. Wolfgang Losken ◽  
Tim Barbano ◽  
Amr Moursi ◽  
...  

Objective: Overexpression of transforming growth factor-beta 2 has been associated with craniosynostosis and resynostosis following surgery. We examined the effects of localized transforming growth factor-beta 2 inhibition on craniofacial phenotype in rabbits with craniosynostosis. Design: Twenty-five New Zealand white rabbits with bilateral coronal craniosynostosis were divided into three treatment groups: (1) suturectomy control (n  =  8); (2) suturectomy with nonspecific, control immunoglobulin G antibody (n  =  6); and (3) suturectomy with anti–transforming growth factor-beta 2 antibody (n  =  11). At 10 days of age, a coronal suturectomy was performed on all rabbits. The sites in groups 2 and 3 were immediately filled with a slow-resorbing collagen gel mixed with either immunoglobulin G or anti–transforming growth factor-beta 2 antibody. Computed tomography scans of each rabbit were acquired at ages 10, 25, and 84 days. Craniofacial landmarks were collected from three-dimensional computed tomography reconstructions, and growth and form were compared among the three groups. Results: Rabbits treated with anti–transforming growth factor-beta 2 antibody differed in form at 84 days of age compared with suturectomy control rabbits, specifically in the snout and posterior neurocranium. Growth in some areas of the skull was greater in rabbits from the anti–transforming growth factor-beta 2 group than in suturectomy control rabbits, but not significantly greater than in IgG control rabbits. Conclusions: We find support for the hypothesis that transforming growth factor-beta 2 inhibition alters adult form, but these changes do not appear to be localized to the suturectomy region. Slight differences in form and growth between the two control groups suggest that the presence of the collagen vehicle itself may affect skull growth.


RSC Advances ◽  
2016 ◽  
Vol 6 (88) ◽  
pp. 85457-85467 ◽  
Author(s):  
Sara G. Mina ◽  
Wei Wang ◽  
Qingfeng Cao ◽  
Peter Huang ◽  
Bruce T. Murray ◽  
...  

A novel microfluidic device with a three-dimensional cell culture chamber was developed to study the role of shear stress magnitude and transforming growth factor-beta 1 (TGF-β1) on endothelial to mesenchymal transformation (EndMT).


Sign in / Sign up

Export Citation Format

Share Document